FDA mulls compounding for peptides previously flagged over safety risks BioSpace The Emerging Risk of Peptides in Supplements LegitScript I spent 4 months reporting on the peptide BPC 157 and its unlikely journey from a research lab in post communist Croatia to today's MAHA movement. Ask me anything. : r IAmA Peptide Therapy in Boise Specialized Treatment for First Responders Blueline Wellness The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BPC 157 Peptide Therapy Doctors Supplement Store